IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aligos Therapeutics Inc

CUSIP: 01626L105 | 160 institutional holders

Quarters

Q1 2026Q4 2025Q4 2024Q2 2024Q1 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Fortitude Family Office, LLC68
0.0% of portfolio›$505
StyleTurnoverLocationFiled
Fortitude Family Office, LLC
68$5050.0%ETFMediumScottsdale, AZ2026-04-16